Skip to main content
Clinical Trials/NL-OMON36325
NL-OMON36325
Completed
Not Applicable

Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium - EBCA

C2 Therapeutics, Inc.0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
C2 Therapeutics, Inc.
Enrollment
15
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a) Patient must have a minimum of 2\.0 cm of non\-ulcerated, non\-inflammatory columnar\-lined esophagus or squamous esophageal lined tissue suitable for ablation. A patient may be treated with up to 2 zones of ablation
  • b) Patient is 18 to 80 years of age at the time of consent (inclusive).
  • c) Patient has provided written Informed Consent Form (IFC) using a form that has been approved by the Institution\*s reviewing IRB/EC.
  • d) Patient is willing and able to comply with study requirements.
  • e) Patient\*s esophagectomy is clinically necessary due to reasons unrelated to this study.
  • f) Patient is deemed operable per standard institutional criteria.

Exclusion Criteria

  • a) Patient has a known history of unresolved drug or alcohol dependency that would limit ability to comprehend or follow instructions related to IFC, post treatment instructions or follow\-up guidelines.
  • b) Patient refuses or is unable to provide written informed consent.
  • c) Patient has or is currently undergoing endoscopic ablation therapy within 4 cm from the proposed treatment area including, but not limited to cryospray therapy, laser treatment, photodynamic therapy, multi\-polar electro coagulation, endoscopic mucosal resection, radiofrequency ablation or argon plasma coagulation.
  • d) Patient has esophageal narrowing limiting access to the intended site of ablation.
  • e) Patient is undergoing or has recently undergone chemotherapy (within 15 days or WBC below normal by institutional criteria or standards).
  • f) Patient is undergoing or has recently undergone radiation therapy which involved the esophagus (within 15 days or WBC below normal by institutional criteria or standards).

Outcomes

Primary Outcomes

Not specified

Similar Trials